APA

Orange D. E., Jegathesan M., Blachère N. E., Frank M. O., Scher H. I., Albert M. L. & Darnell R. B. (20041018). Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy. : Prostate cancer and prostatic diseases.

Chicago

Orange D E, Jegathesan M, Blachère N E, Frank M O, Scher H I, Albert M L and Darnell R B. 20041018. Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy. : Prostate cancer and prostatic diseases.

Harvard

Orange D. E., Jegathesan M., Blachère N. E., Frank M. O., Scher H. I., Albert M. L. and Darnell R. B. (20041018). Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy. : Prostate cancer and prostatic diseases.

MLA

Orange D E, Jegathesan M, Blachère N E, Frank M O, Scher H I, Albert M L and Darnell R B. Effective antigen cross-presentation by prostate cancer patients' dendritic cells: implications for prostate cancer immunotherapy. : Prostate cancer and prostatic diseases. 20041018.